Newron Pharmaceuticals S.p.A. carries a market capitalization of 248.84M, placing it among publicly traded companies globally.
| Market Cap | 248.84M |
| Enterprise Value | N/A |
Newron Pharmaceuticals S.p.A.'s stock has gained approximately 68.21378% over the past 52 weeks. The 50-day moving average sits at 13.38, while the 200-day moving average is 16.71.
| Beta (5Y) | N/A |
| 52-Week Price Change | 68.21378% |
| 50-Day Moving Average | 13.38 |
| 200-Day Moving Average | 16.71 |
| Average Volume (20 Days) | N/A |